NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.50 +0.02 (+0.03%) GOLD FUTURES
2,320.80 -10.40 (-0.45%) DOW
38,882.59 +30.32 (+0.08%) Bitcoin GBP
50,478.37 +55.76 (+0.11%)
Protalix BioTherapeutics, Inc. (PLX)
| Previous close | 1.1100 |
| Open | 1.1300 |
| Bid | 1.1300 x 1000 |
| Ask | 1.1400 x 1800 |
| Day's range | 1.1200 - 1.1600 |
| 52-week range | 1.0700 - 3.1300 |
| Volume | |
| Avg. volume | 388,067 |
| Market cap | 82.847M |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 12.56 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript March 14, 2024 Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.03. Protalix BioTherapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
- GuruFocus.com
Protalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023
PLX Sees Regulatory Approvals and Commercial Progress Amidst Financial Growth
- Insider Monkey
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript November 6, 2023 Protalix BioTherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.07. Operator: Good morning, ladies and gentlemen. And welcome to the Protalix Biotherapeutics Third Quarter 2023 Financial and Business Results Conference Call. As a reminder, this conference is being recorded. I […]
